Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Spirituality, Religiosity, and Immune Functioning

This study has been completed.
Sponsor:
Information provided by:
National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:
NCT00066924
First received: August 7, 2003
Last updated: June 23, 2005
Last verified: May 2005

August 7, 2003
June 23, 2005
September 2003
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00066924 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Spirituality, Religiosity, and Immune Functioning
Not Provided

The purpose of this study is to determine whether religiosity and spirituality are related to immune functioning, as measured by interleukin-6 blood plasma level, among terminally ill cancer patients.

Not Provided
Observational
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Not Provided
Not Provided
  • Cancer
  • Depression
  • Dying Process
Not Provided
Not Provided
McClain CS, Rosenfeld B, Breitbart W. Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients. Lancet. 2003 May 10;361(9369):1603-7.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
120
June 2004
Not Provided

Inclusion criteria:

  • Inpatient at Calvary Hospital
  • Diagnosis of terminal cancer
  • Score of 20 or above on Mini-Mental State Exam

Exclusion criteria:

  • Presence of a psychiatric disorder that would preclude the production of meaningful data
Both
21 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00066924
F31 AT001769-01
Not Provided
Not Provided
National Center for Complementary and Alternative Medicine (NCCAM)
Not Provided
Principal Investigator: Barry Rosenfeld, PhD Fordham University
Principal Investigator: William Breitbart, MD Memorial Sloan-Kettering Cancer Center
National Center for Complementary and Alternative Medicine (NCCAM)
May 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP